Article thumbnail
Location of Repository

Vaccination therapy for non-small-cell lung cancer

By Kristof Cuppens and Johan Vansteenkiste

Abstract

Recent advances in our understanding of cancer immunology resulted in the development of promising therapeutic agents for either nonantigen-specific immunotherapy, for example, monoclonal antibodies targeting immune checkpoints on the T-cell lymphocyte, and antigen-specific immunotherapy or vaccination. Here, we review the recently reported results from randomized controlled trials (RCTs) with the latter approach.status: publishe

Topics: Cancer Vaccines, Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Randomized Controlled Trials as Topic, Survival Analysis, Treatment Outcome, Vaccination
Publisher: 'Ovid Technologies (Wolters Kluwer Health)'
Year: 2014
DOI identifier: 10.1097/CCO.0000000000000052
OAI identifier: oai:lirias2repo.kuleuven.be:123456789/531778
Provided by: Lirias
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://lirias.kuleuven.be/han... (external link)
  • https://lirias.kuleuven.be/bit... (external link)
  • http://meta.wkhealth.com/pt/pt... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.